Genpharmasec Limited
BSE: GENPHARMA · Trading & Distributors · sector
Key numbers
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 157 companies in Trading & Distributors (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹10 cr vs borrowings ₹33 cr (FY26): borrowings are higher by ₹23 cr.
- Operating profit covered interest 1.0x in the last 12 months.
- Net loss in 3 of the last 6 quarters.
- No dividend in the last 5 financial years.
- Price ₹0.99 on 2026-10-26: -46.2% from the 52-week high, +32.0% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | 14 | 12 | 33 | 40 | 55 | 50 |
| EBITDA | -1 | 1 | -0 | -1 | 2 | 1 |
| OPM % | -7.1% | 7.8% | -1.4% | -3.1% | 3.6% | 1.9% |
| Other income | 1 | 1 | 0 | 1 | 1 | 0 |
| Net profit | -0 | 1 | -1 | -0 | 1 | 0 |
| EPS (₹) | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 |
| Revenue YoY | +295.6% | +312.9% | ||||
| Profit YoY | – | -78.7% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 27 | 26 | 30 | 34 | 140 | 178 |
| EBITDA | -1 | 0 | 0 | 0 | 1 | 1 |
| Net profit | -0 | 1 | 0 | 1 | 2 | -0 |
| EPS (₹) | -0.01 | 0.04 | – | 0.01 | 0.01 | 0.06 |
| Revenue growth | -6.6% | +19.2% | +10.9% | +315.0% | – | |
| Profit growth | – | -95.6% | +2,360.0% | +30.1% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +76.3% | – | – |
| Net profit | +12.4% | – | – |
| EPS | -37.0% | – | – |
| Share price | – | -39.1% (2y) | -43.0% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 65 | 66 |
| Borrowings | 3 | 33 |
| Cash & equivalents | 5 | 10 |
| Total assets | 80 | 138 |
| Fixed assets | 6 | 21 |
| Capital work in progress | 0 | 0 |
| Investments | 19 | 2 |
| Receivables | 14 | 29 |
| Inventory | 8 | 14 |
| Payables | 8 | 32 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 3 | -18 |
| Cash from investing | -15 | 13 |
| Cash from financing | -1 | 4 |
| Capex | 6 | 1 |
| Free cash flow | -3 | -18 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 1.9% | 2.4% |
| ROCE % | 3.4% | 2.2% |
| Debtor days | 147 | 76 |
| Inventory days | 101 | 39 |
| Payable days | 102 | 90 |
| Cash conversion cycle (days) | 146 | 25 |
| Working capital days | 198 | 87 |
Peers in Trading & Distributors
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| REDINGTON | ₹28,671 cr | 16.9x | 2.8x | 18.0% | 18.4% | 1.9% | +14.5% | 1.85% |
| MMTC | ₹7,599 cr | 17.0x | 3.6x | 23.4% | 25.6% | 10,805.5% | -90.1% | – |
| MSTCLTD | ₹4,097 cr | 17.5x | 4.5x | 28.5% | 30.1% | 61.1% | -20.0% | 1.30% |
| CNL | ₹1,607 cr | 24.7x | 4.4x | 22.4% | 16.3% | 3.6% | +25.2% | 0.05% |
| BNAGROCHEM | ₹1,267 cr | 45.5x | 2.7x | 4.0% | 0.7% | -0.5% | – | – |
| YSL | ₹757 cr | 8.3x | 0.6x | 7.1% | 0.3% | 2.1% | +0.3% | 2.03% |
| SHIVAUM | ₹738 cr | 64.9x | 6.1x | 10.2% | 11.3% | 3.1% | – | – |
| STCINDIA | ₹594 cr | 0.9x | 1.0x | 228.5% | 108.2% | – | – | – |
| PERVASIVE | ₹587 cr | 0.1x | 6.5x | -0.2% | -0.1% | -0.9% | – | – |
| GENPHARMA | ₹55 cr | 16.5x | 0.8x | -0.2% | 1.5% | 0.7% | +76.3% | – |
Business segments (2026-06-30)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Pharmaceuticals | ₹45 cr | 90.1% | ₹2 cr | 5.0% |
| Manufacturing & Processing | ₹3 cr | 5.5% | ₹-1 cr | -46.0% |
| Unallocable | ₹2 cr | 4.4% | ₹0 cr | -1.1% |
| Laboratory Testing | ₹0 cr | – | ₹-0 cr | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Services |
| Industry | Trading & Distributors |
| Sub-industry | Trading & Distributors |
| Symbol | GENPHARMA |
| BSE code | 531592 |
| ISIN | INE861N01036 |
| Face value | ₹1.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.